This GLP-1 receptor agonist slows gastrointestinal transit and reduces appetite, leading to harder stools and decreased bowel frequency
Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-L-tryptophan positron emission tomography (PET)
See more WADA names substances according to the following convention: For substances that have been given an International Non-proprietary Name (INN), as published by the World Health Organisation, this name is used first
This can potentially lead to the development of anti-drug antibodies, which could reduce the effectiveness of future tirzepatide treatments even with fresh medication
OTHERS 10.2.4 OTHERS 10.3 NUTRACEUTICALS 10.4 MEDICAL 10.4.1 RESPIRATORY HEALTH 10.4.2 INTRAVENOUS (IV) THERAPY 10.4.3 CHRONIC ILLNESS MANAGEMENT 10.4.4 OTHERS 10.5 SPORTS NUTRITION 10.6 COSMETICS (SKIN CARE) 10.6.1 CREAM 10.6.2 LOTION 10.6.3 SERUM 10.6.4 OTHERS 10.7 PHARMACEUTICALS 10.7.1 SYRUPS 10.7.2 TABLETS 10.7.3 OTHERS 10.8 OTHERS 11 GLOBAL GLUTATHIONE MARKET, COMPANY LANDSCAPE 11.1 COMPANY SHARE ANALYSIS: GLOBAL 11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 11.3 COMPANY SHARE ANALYSIS: EUROPE 11.4 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA 11.5 MERGERS & ACQUISITIONS 11.6 NEW PRODUCT DEVELOPMENT & APPROVALS 11.7 EXPANSIONS & PARTNERSHIP 11.8 REGULATORY CHANGES 12 GLOBAL GLUTATHIONE MARKET, BY GEOGRAPHY, 2022-2031 (USD MILLION) (KILO TONS) OVERVIEW (ALL SEGMENTATION PROVIDED ABOVE IS REPRESNTED IN THIS CHAPTER BY COUNTRY) 12.1 NORTH AMERICA 12.1.1 U.S
